4.320USD-3.09%Mkt Cap: —P/E: —1d ago
Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests,…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value126.24M $
Revenue (TTM)1.67M $
Gross Profit814.00K $
Net Income (TTM)-49.36M $
Revenue/Share0.0490 USD
Last Price4.320 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees55
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-3.65
EV/Revenue75.59
P/S—
P/B-6.62
EPS (TTM)-0.77
EPS (Forward)—
52W Range
4.19947% of range4.458
52W High4.458 USD
52W Low4.199 USD
Profitability
Gross Margin48.74%
Oper. Margin-3815.06%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA-57.82%
Growth
Revenue Growth-53.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-27.08M $
CapEx (TTM)—
FCF Margin-1125.12%
FCF Yield—
Net Debt-15.13M $
Net Debt/EBITDA0.44
Balance Sheet
Debt/Equity—
Current Ratio2.00
Quick Ratio1.75
Book Value/Sh-0.6530 USD
Cash/Share0.5430 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.05:1
Split DateJul 25, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.40.66M
Float10.40M
Insiders21.00%
Institutions56.43%
Technical
SMA 501.768 (+144.3%)
SMA 2001.768 (+144.3%)
Beta1.82
S&P 52W Chg18.16%
Avg Vol (30d)1.59K
Avg Vol (10d)410
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—